glp-1 heart attack receptor agonists and myocardial metabolism in atrial fibrillation GLP-1 Drugs Cut Risk of
Description
Many healthcare startups that once sold exclusively to consumers are now switching up their models to sell to other businesses to lock down less volatile revenue streams
Gentle Patches isnt a traditional weight-loss clinic
By indication, type 2 diabetes accounted for 87.36% revenue in 2025, but obesity and weight-management prescriptions are forecast to grow at 11.57% CAGR to 2031
N Engl J Med 2021;385:50315
The study found that the medical indication leading to the prescription made a big difference in fill rates
